Primary record
GLPG-0634|||N-[5-[4-[(1,1-Dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide
- 库存
- 5,004 克
- 纯度
- 98.9 %
- CAS
- 1206161-97-8
化合物标识与属性
- CAS
- 1206161-97-8
- PubChem CID
- 49831257
- SMILES
- C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5
- Canonical SMILES
- O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1
名称与同义词
- Filgotinib
- 1206161-97-8
- Jyseleca
- GLPG0634
- filgotinibum
- GLPG0634 analogue
- Tasocitinib
- Filgotinib-d4
- Filgotinib [INN]
- GLPG0634 analog
- GLPG-0634
- Filgotinib maleate
- Filgotinib (GLPG0634)
- Filgotinib (Standard)
- Filgotinib [USAN:INN]
- GLPG0634-analogue
- Filgotinib hydrochloride
- Filgotinib(GLPG0634)
- Filgotinib (USAN/INN)
- GS-6034 FREE BASE
- RefChem:921607
- 3XVL385Q0M
- FILGOTINIB [USAN]
- GPLG0634
- UNII-3XVL385Q0M
- D0SG7B
- GLPG 0634
- Filgotinib(GLPG0634)?
- FILGOTINIB [WHO-DD]
- 1206101-20-3
- MFCD20527867
- Filgotinib (GLPG-0634)
- C21H23N5O3S
- SCHEMBL253559
- DTXSID80152935
- Filgotinib pound GLPG0643)
- GTPL7913
- orb1307080
- CHEMBL3301607
- DTXCID7075426
- N-(5-(4-((1,1-dioxidothiomorpholino)methyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
- AMY3802
- EX-A741
- SYN1158
- BDBM103727
- GLXC-90126
- HMS3653P15
- HMS3673E07
- AOB87315
- BCP08496
- RGD09550
- 2566AH
- EBC-13676
- HY-18300R
- NSC800100
- s7605
- ZINC96174616
- AKOS025291103
- G146034
- 5-Thioxo-pyrrolidine-2-carboxylic acid
- CCG-268951
- CS-2284
- DB14845
- NSC-800100
- SB16799
- G-146034
- KS-0000063T
- NCGC00345855-01
- NCGC00345855-07
- AK171369
- AS-16295
- BC600462
- BF159062
- DA-33603
- DA-33604
- HY-18300
- N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide
- B1130
- FT-0700114
- FT-0761510
- SW220020-1
- N-[5-[4-[(1,1-Dioxido-4-thiomorpholinyl)methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide
- A14232
- D10871
- P12798
- US8563545, 1
- EN300-7419864
- A892158
- SYN1158;GLPG 0634; GLPG-0634; Filgotinib
- BRD-K16803204-001-01-6
- Q19904163
- Z2037280227
- G-146034-101
- N-(5-(4-((1,1-dioxidothiomorpholino)methyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide.
- Small molecule, JAK1/JAK2 inhibitor (rheumatoid arthritis), Galapagos/GSK
- 2041095-50-3
- CYCLOPROPANECARBOXAMIDE, N-(5-(4-((1,1-DIOXIDO-4-THIOMORPHOLINYL)METHYL)PHENYL)(1,2,4)TRIAZOLO(1,5-A)PYRIDIN-2-YL)-
- GLPG-0634|||N-[5-[4-[(1,1-Dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide
- N-(5-(4-((1,1-dioxo-1,4-thiazinan-4-yl)methyl)phenyl)-(1,2,4)triazolo(1,5-a)pyridin-2-yl)cyclopropanecarboxamide
- N-(5-(4-((1,1-dioxo-1lambda6-thiomorpholin-4-yl)methyl)phenyl)-(1,2,4)triazolo(1,5-a)pyridin-2-yl)cyclopropanecarboxamide
- N-(5-(4-((1,1-OXO-.LAMBDA.6-THIOMORPHOLIN-4-YL)METHYL)PHENYL((1,2,4)TRIAZOLO(1,5-A)PYRIDIN-2-YL)CYCLOPROPANECARBOXAMIDE
- n-(5-(4-((6-cyanopyridin-3-yl)methoxy)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
- N-(5-{4-[(1,1-Dioxidothiomorpholin-4-Yl)methyl]phenyl}[1,2,4]triazolo[1,5-A]pyridin-2-Yl)cyclopropanecarboxamide
- N-(5-{4-[(1,1-Dioxo-1lambda~6~-thiomorpholin-4-yl)methyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
- N-(5-{4-[(1,1-dioxo-1lambda6-thiomorpholin-4-yl)methyl]phenyl}-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
- N-(5-{4-[(6-Cyano-3-pyridinyl)methoxy]phenyl}[1,2,4]triazolo[1,5- a]pyridin-2-yl)cyclopropanecarboxamide
- N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl] cyclopropanecarboxa